Beam Therapeutics Inc. Quarterly Return On Assets in % from Q3 2020 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Beam Therapeutics Inc. quarterly/annual Return On Assets history and growth rate from Q3 2020 to Q3 2024.
  • Beam Therapeutics Inc. Return On Assets for the quarter ending September 30, 2024 was -10.9 %, a 53.7% increase year-over-year.
  • Beam Therapeutics Inc. annual Return On Assets for 2023 was -9.75 %, a 53.1% increase from 2022.
  • Beam Therapeutics Inc. annual Return On Assets for 2022 was -20.8 %, a 40.9% increase from 2021.
  • Beam Therapeutics Inc. annual Return On Assets for 2021 was -35.2 %, a 38.9% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -10.9 +12.7 +53.7% Jul 1, 2024 Sep 30, 2024
Q2 2024 -10.7 +13.7 +56.2% Apr 1, 2024 Jun 30, 2024
Q1 2024 -9.86 +13.4 +57.6% Jan 1, 2024 Mar 31, 2024
Q4 2023 -9.75 +11 +53.1% Oct 1, 2023 Dec 31, 2023
Q3 2023 -23.6 -1.44 -6.5% Jul 1, 2023 Sep 30, 2023
Q2 2023 -24.3 -7.32 -43% Apr 1, 2023 Jun 30, 2023
Q1 2023 -23.3 -4.1 -21.4% Jan 1, 2023 Mar 31, 2023
Q4 2022 -20.8 +14.4 +40.9% Oct 1, 2022 Dec 31, 2022
Q3 2022 -22.2 +28.1 +55.9% Jul 1, 2022 Sep 30, 2022
Q2 2022 -17 +53.4 +75.8% Apr 1, 2022 Jun 30, 2022
Q1 2022 -19.2 +65.7 +77.4% Jan 1, 2022 Mar 31, 2022
Q4 2021 -35.2 +22.4 +38.9% Oct 1, 2021 Dec 31, 2021
Q3 2021 -50.3 -2.21 -4.6% Jul 1, 2021 Sep 30, 2021
Q2 2021 -70.4 Apr 1, 2021 Jun 30, 2021
Q1 2021 -84.9 Jan 1, 2021 Mar 31, 2021
Q4 2020 -57.6 Oct 1, 2020 Dec 31, 2020
Q3 2020 -48.1 Jul 1, 2020 Sep 30, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.